Post-Transplant Triplet Bests Lenalidomide Maintenance Alone in Myeloma
(MedPage Today) -- Use of a triple-drug maintenance combination appeared to improve progression-free survival (PFS) in patients with newly diagnosed multiple myeloma following induction therapy and autologous stem-cell transplantation, an interim...
Source: MedPage Today Surgery - Category: Surgery Source Type: news
More News: Myeloma | Revlimid | Stem Cell Therapy | Stem Cells | Surgery | Transplant Surgery | Transplants